Reckitt v. Aurobindo, C.A. No. 14-1203-LPS,November 3, 2016.
Stark, C. J. Claim construction opinion issues regarding four terms from two patents. A Markman hearing took place on August 9, 2016.
The disputed terms are related to controlled-release formulations of the drug guaifenesin. The following terms were considered:
-
“portion”
-
“modified release drug product”
-
“release-delaying matrix”
-
“immediate release formulation wherein the guaifenesin becomes bioavailable in a subject's stomach”
